Koyfin Home > Directory > Health Care > Acorda Therapeutics > Cash from Financing Activities

Acorda Therapeutics Cash from Financing Activities Chart (ACOR)

Acorda Therapeutics annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Acorda Therapeutics Cash from Financing Activities for the quarter ending June 06, 2020 was $0m a 0.00% decrease of 0m year over year
  • Acorda Therapeutics Cash from Financing Activities for the last 12 months ending June 06, 2020 was $-61m a 98.99% decrease of -61m year over year
  • Acorda Therapeutics Annual Cash from Financing Activities for 2019 was $-61m a 121.13% decrease of -73m from 2018
  • Acorda Therapeutics Annual Cash from Financing Activities for 2018 was $13m a -380.73% decrease of -49m from 2017
  • Acorda Therapeutics Annual Cash from Financing Activities for 2017 was $62m a 25.34% increase of 16m from 2016
Other Cash Flow Metrics:
  • Acorda Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $78m a 23.00% increase of 18m year over year
  • Acorda Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $60m a 1.90% increase of 1m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Cash from Financing Activities Data

06/2020$0m
03/2020$-2m
12/2019$-60m
09/2019$0m
06/2019$0m
03/2019$-1m
12/2018$0m
09/2018$2m
06/2018$9m
03/2018$2m

Annual ACOR Cash from Financing Activities Data

2019$-61m
2018$13m
2017$62m
2016$46m
2015$18m
2014$353m
2013$12m
2012$3m
2011$2m
2010$1m